BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25169048)

  • 1. Individual differences in novelty-seeking behavior in spontaneously hypertensive rats: Enhanced sensitivity to the reinforcing effect of methylphenidate in the high novelty-preferring subpopulation.
    dela Peña I; Gonzales EL; de la Peña JB; Kim BN; Han DH; Shin CY; Cheong JH
    J Neurosci Methods; 2015 Aug; 252():48-54. PubMed ID: 25169048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
    dela Peńa IC; Ahn HS; Choi JY; Shin CY; Ryu JH; Cheong JH
    Behav Pharmacol; 2011 Feb; 22(1):31-9. PubMed ID: 21160423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
    Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
    Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.
    Somkuwar SS; Kantak KM; Bardo MT; Dwoskin LP
    Pharmacol Biochem Behav; 2016 Feb; 141():66-77. PubMed ID: 26657171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD).
    dela Peña I; Kim HJ; Sohn A; Kim BN; Han DH; Ryu JH; Shin CY; Noh M; Cheong JH
    Behav Brain Funct; 2014 May; 10():17. PubMed ID: 24884696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.
    Jordan CJ; Harvey RC; Baskin BB; Dwoskin LP; Kantak KM
    Drug Alcohol Depend; 2014 Jul; 140():25-32. PubMed ID: 24811203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder.
    Marusich JA; McCuddy WT; Beckmann JS; Gipson CD; Bardo MT
    Behav Pharmacol; 2011 Dec; 22(8):794-804. PubMed ID: 22015805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Methylphenidate Alters Tonic and Phasic Glutamate Signaling in the Frontal Cortex of a Freely-Moving Rat Model of ADHD.
    Miller EM; Quintero JE; Pomerleau F; Huettl P; Gerhardt GA; Glaser PEA
    Neurochem Res; 2019 Jan; 44(1):89-101. PubMed ID: 29397534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment.
    dela Peña I; Lee JC; Lee HL; Woo TS; Lee HC; Sohn AR; Cheong JH
    Neurosci Lett; 2012 Apr; 514(2):189-93. PubMed ID: 22414863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
    van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
    Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD).
    Pires VA; Pamplona FA; Pandolfo P; Prediger RD; Takahashi RN
    Behav Brain Res; 2010 Dec; 215(1):39-44. PubMed ID: 20600342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder.
    Botanas CJ; Lee H; de la Peña JB; Dela Peña IJ; Woo T; Kim HJ; Han DH; Kim BN; Cheong JH
    Physiol Behav; 2016 Mar; 155():30-7. PubMed ID: 26656767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior.
    Wultz B; Sagvolden T; Moser EI; Moser MB
    Behav Neural Biol; 1990 Jan; 53(1):88-102. PubMed ID: 2302145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-novelty-preference rats are predisposed to compulsive cocaine self-administration.
    Belin D; Berson N; Balado E; Piazza PV; Deroche-Gamonet V
    Neuropsychopharmacology; 2011 Feb; 36(3):569-79. PubMed ID: 20980989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate treatment in the spontaneously hypertensive rat: influence on methylphenidate self-administration and reinstatement in comparison with Wistar rats.
    dela Peña I; Yoon SY; Lee JC; dela Peña JB; Sohn AR; Ryu JH; Shin CY; Cheong JH
    Psychopharmacology (Berl); 2012 May; 221(2):217-26. PubMed ID: 22086360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.
    Jordan CJ; Taylor DM; Dwoskin LP; Kantak KM
    Behav Brain Res; 2016 Jan; 297():165-79. PubMed ID: 26467602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders.
    Wooters TE; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2006 Sep; 188(1):18-27. PubMed ID: 16896959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
    Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
    Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
    Dela Peña I; Kim BN; Han DH; Kim Y; Cheong JH
    Arch Pharm Res; 2013 Apr; 36(4):400-10. PubMed ID: 23471559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.
    Harvey RC; Sen S; Deaciuc A; Dwoskin LP; Kantak KM
    Neuropsychopharmacology; 2011 Mar; 36(4):837-47. PubMed ID: 21150910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.